Informa Medicaid Drug Rebate Program Summit

On a panel titled “Ask the Attorneys – What Keeps Them Up at Night?,” Stephanie will participate in an open Q&A with external counsel about the latest issues in drug pricing and government price reporting. The panel will be moderated by Michael Kurland, Vice President of Revenue Management & Compliance at life sciences company EVERSANA.

Stephanie will also co-lead the “Closed-Door Executive Strategy Summit,” in which senior leaders from across the pharmaceutical industry will participate in discussions about the political outlook for drug pricing and health care over the next three years, tackling market access issues, and implementing effective collaboration strategies to work across organizational boundaries. Stephanie will moderate the discussions alongside executives from three major pharmaceutical companies.

The Medicaid Drug Rebate Program Summit is designed to bring together government regulators, industry leaders, and manufacturers to deliver content on the complex, ever-evolving guidelines regulating Medicaid, including 340B, the Final Rule, state drug price transparency, rebate credits, and more.